ESTRO Multidisciplinary Management of Breast Cancer 2017

• We can classify pN0 women into large (≥20%), intermediate (10-19%), and lower (<10%) predicted absolute 10-year recurrence benefit

• Then look to see what happens in these three groups in terms of breast cancer mortality

21